Abstract
A double-blind, randomized, group comparative study was performed in hypogonadal male patients in order to compare the effects on sexual activity and mental state of testosterone undecanoate (TU) and mesterolone (M). The TU-treated group contained 12 patients, and the M-treated group contained 14 patients. The variables of sexual activity and of mental state were scored and evaluated statistically by means of the nonparametric randomization test for 2 independent groups. TU induced a marked improvement of the sexual activity and of the mental state. After 4 weeks of treatment the effects were significantly better than in the M-treated group: libido (p < 0.001), erections (p < 0.01), ejaculations (p < 0.05) and mental state (p < 0.001).
Similar content being viewed by others
References
Nieschlag E., Mauss J., Coert A., Kicovic P. Plasma androgen levels in man after oral administration of testosterone or testosterone undecanoate. Acta Endocrinol. (Kbh.) 79: 366, 1975.
Franchi F., Luisi M., Kicovic P.M. Pilot clinical and radioimmunological evaluation of the effects of orally administered testosterone undecanoate in hypogonadal men. Intern. J. Androl. (Suppl.) 1: 141, 1978.
Metelko Z., Rocic B., Skrabalo Z. Treatment of hypogonadal male patients with oral testosterone undecanoate: preliminary communication. Inter. J. Androl. (Suppl.) 1: 150, 1978.
Sarris S., Swyer G.M., Lawrence D.M. Hypogonadal men treated with oral testosterone undecanoate. Acta Eur. Fertil. 8; 297, 1977.
Mies R., Krempl S. Effects of oral testosterone undecanoate on plasma hormones and clinical symptomatology in hypogonadal male patients. Acta Endocrinol. (Suppl.) (Kbh.) 212: 119, 1977.
Franchimont P., Kicovic P.M., Mattei A., Roulier R. Effects of oral testosterone undecanoate in hypogonadal male patients. Clin. Endocrinol. 9: 313, 1978.
Franchi F., Luisi M., Kicovic P.M. Long-term study of oral testosterone undecanoate in hypogonadal males. Intern. J. Androl. 1: 270, 1978.
Romanelli R., Cini F., Barletta D., Bomoli R., Franchi F., Alicicco E., Kicovic P.M., Luisi M. A new type of androgen therapy for male climacteric. In: Tronchetti F., Menchini-Fabris G.F. (Eds.), Giornate endocrinologiche pisane. Pacini Ed., Pisa, 1977, p. 779.
Benkert O. Sexual impotence, neuroendocrine and pharmacotherapeutic examinations. Springer Verlag, New York, 1977, vol. 15, p. 66.
Wang C., Burger H.G., de Kretser D.M., Dulmanis A., Hudson B., Keogh E.J., Suthers M.B. Effect of mesterolone on serum FSH, LH and plasma testosterone in normal men. Andrologia 6: 111, 1974.
Comhaire F. Influence of current modes of treatment in male infertility on the hypothalamic-pituitary-testicular function. In: Schellen T. (Ed.), Releasing factors and gonadotropic hormones in male and female sterility. European Press Medikon, Gent, 1975, p. 117.
Gordon R.D., Thomas M.J., Poynting J.M., Stocks A.E. Effect of mesterolone on plasma LH, FSH and testosterone. Andrologia 7: 287, 1975.
Naftolin F., Ryan K.J., Davies I.J, Reddy V.V., Flores F., Pietro Z., Kuhn M. The formation of estrogens by central neuroendocrine tissues. Recent Prog. Horm. Res. 31: 295, 1975.
Baum M.J., Vreeburg J.T.M. Differential effects of the anti-estrogen MER-25 and of three 5a-reduced androgens on mounting and lordosis behavior in the rat. Horm. Behav. 7: 87, 1976.
Hamburger-Bar R., Rigter H. Peripheral and central androgenic stimulation of sexual behavior of castrated male rats. Acta Endocrinol. (Kbh.) 84: 813, 1977.
Naftolin F., Ryan K.J., Davies I.J., Petro Z., Kuhn M. The formation and metabolism of estrogens in brain tissues. Adv. Bioscien. 15: 105, 1975.
Breuer H., Gütgemann D. Wirkung von 1α-Methyl-5α-androstan-17β-ol-3-on (Mesterolon) auf die Steroidausscheidung beim Menschen. Arzneim. Forsch. 16: 759, 1966.
Author information
Authors and Affiliations
Additional information
Supported by Grant no. 77.01689.04/115.1130 of the National Research Council (Rome).
Rights and permissions
About this article
Cite this article
Luisi, M., Franchi, F. Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients. J Endocrinol Invest 3, 305–308 (1980). https://doi.org/10.1007/BF03348281
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348281